Dr. F. Stephen Hodi led a clinical trial study that found patients with metastatic melanoma who were treated with ipilimumab, survived 50 percent longer if they simultaneously received an immune stimulant.
Dana-Farber was recognized as a Leader in LGBT Healthcare Equality by the Human Rights Campaign Foundation, the educational arm of the country's largest lesbian, gay, bisexual and transgender civil rights organization.
Tags: Honors, PatientSupport, YawkeyCenter
was mentioned for its research into immunotherapy.
A study led by Sharon Bober, PhD, showed a half-day educational program can help women, having ovary-removing surgery as a cancer prevention measure, deal with sexual or psychological side effects.
Dr. Paul Nguyen led a study looking at the link between certain prostate cancer treatments and heart-related deaths.
Alexi Wright’s research on the use of hospice in the final days of
ovarian cancer has been published in the Journal of Clinical Oncology.
Tags: EndOfLife, OvarianCancer
Dr. Charles Fuchs led a study published in Nature Genetics that identified in about 20 percent of colorectal and endometrial cancers, a genetic mutation that had been overlooked in recent large, comprehensive gene searches.
Tags: ColonCancer, GynecologicCancers
Todd R. Golub, MD, Margaret A. Shipp, MD, and Bruce M. Spiegelman, PhD, were elected to the Institute of Medicine, a nongovernmental organization that advises the nation on issues related to biomedical science, medicine, and health.
Dr. Alexi Wright led a study that found increasing the use of hospice in the final days of ovarian cancer does not offset intensive end-of-life care in older women.
Dr. Eric Winer commented on a blood test that could reduce the number of women who need chemotherapy after tumor removal surgery.
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: